On August 23, 2023 Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, reported that its management team will participate in the following upcoming investor conferences in September (Press release, Arcus Biosciences, AUG 23, 2023, View Source [SID1234634665]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2023 Wells Fargo Healthcare Conference
Date: Wednesday, September 6th, 2023 at 10:15 a.m. ET
Location: Boston, MA
Format: Fireside Chat

Citi 18th Annual BioPharma Conference
Date: Wednesday, September 6th, 2023 at 3:30 p.m. ET
Location: Boston, MA
Format: Company Panel — Immuno-Oncology

Morgan Stanley 21st Annual Global Healthcare Conference
Date: Tuesday, September 12th, 2023 at 4:15 p.m. ET
Location: New York, NY
Format: Fireside Chat

2023 Cantor Fitzgerald Global Healthcare Conference
Date: Tuesday, September 26th, 2023 at 10:20 a.m. ET
Location: New York, NY
Format: Fireside Chat

Live webcasts of the fireside chats and panel will be available by visiting the "Investors & Media" section of the Arcus Biosciences website at www.arcusbio.com. Replays will be available following the live event.